---
title: "Dron Gauchan, M.D. | Sutter Health"
url: "https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Investigators](https://www.sutterhealth.org/research/investigators) /
4.  Dron Gauchan, M.D.

![Dron Gauchan, M.D.](https://dyn.mktgcdn.com/p/0fCyS_704YpY2A8viqU-BukeGy4TDdCv0qxgxLEceLs/fit=crop,gravity=auto,dpr=2,width=240,height=240)

# Dron Gauchan, M.D.

Investigator

[View profile](https://www.sutterhealth.org/find-provider/dr-dron-gauchan-1046248966)

Dr. Gauchan serves as the Associate Program Director and Chair of the Oncology Department. He is a board-certified Hematologist and Medical Oncologist with clinical expertise in lung cancer, glioblastoma, and genitourinary and gastrointestinal malignancies. He is also the Medical Director of Oncology Clinical Informatics.

In addition to his clinical responsibilities, Dr. Gauchan holds several key leadership roles within Sutter Medical Group and Sutter Health. He serves as a member of the Executive Council for the Sutter Health Cancer Service Line and as Director of Pharmacy and Infusion Services. Despite his extensive administrative duties, he remains deeply dedicated to education and mentorship, bringing a wealth of experience in training both medical students and residents. His comprehensive knowledge and commitment to teaching will be an invaluable asset to our Hematology and Oncology Fellowship Program.

Dr. Gauchan completed his Internal Medicine residency at St. Joseph’s University Hospital, followed by a fellowship in Hematology and Medical Oncology at Seton Hall University in New Jersey, where he also served as Chief Fellow. He is actively involved in research and serves as Principal Investigator for multiple cutting-edge clinical trials at the Sutter Roseville Cancer Center. His scholarly contributions include numerous publications in peer-reviewed journals.

As part of his commitment to ongoing education, Dr. Gauchan co-chairs the annual Sutter Health Hematology and Medical Oncology Conference in Sacramento, as well as the San Francisco Lung Cancer Conference in collaboration with faculty from Stanford and UCSF. Fellows in our program will benefit from meaningful participation in these highly regarded conferences.

Outside of his professional endeavors, Dr. Gauchan enjoys traveling, hiking, skiing, and discovering new cultures. His passion for engaging with people from diverse backgrounds and exploring global cuisines reflects the inclusive and open-minded approach he brings to both his personal and professional life.

Dr. Gauchan’ s clinical expertise, leadership, and passion for education will greatly enrich our fellowship program and play a key role in the growth and success of our fellows.

8 Medical Plaza Drive

Suite 300

Roseville, CA 95661

## Clinical trials

-   Clinical trial
    
    ### [Adjuvant Early-stage Non-small Cell Lung Cancer Beamion LUNG-3](https://www.sutterhealth.org/research/clinical-trials/adjuvant-early-stage-non-small-cell-lung-cancer-beamion-lung-3-2084403277)
    
    Beamion LUNG-3: A Randomized, Controlled, Multi-center Trial Evaluating Zongertinib as an Adjuvant Monotherapy Compared With Standard of Care in Patients With Early-stage, Resectable Non-small Cell Lung Cancer (Stage II-IIIB) Harboring Tyrosine Kinase Domain Activating HER2 Mutations
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Adjuvant Monotherapy vs. Standard of Care Early-stage, Resectable Non-small Cell Lung Cancer](https://www.sutterhealth.org/research/clinical-trials/adjuvant-monotherapy-vs-standard-of-care-early-stage-resectable-non-small-cell-lung-cancer-2082765455)
    
    Beamion LUNG-3: A Randomized, Controlled, Multi-center Trial Evaluating Zongertinib as an Adjuvant Monotherapy Compared With Standard of Care in Patients With Early-stage, Resectable Non-small Cell Lung Cancer (Stage II-IIIB) Harboring Tyrosine Kinase Domain Activating HER2 Mutations
    
    **Status:** Coming Soon
    
-   Clinical trial
    
    ### [Adjuvant Non-Small-Cell Lung Cancer C5851005 PADL1NK-005](https://www.sutterhealth.org/research/clinical-trials/adjuvant-non-small-cell-lung-cancer-c5851005-padl1nk-005-2064313501)
    
    PADL1NK-005: A Randomized, Phase 3, Open-Label Study to Evaluate PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Advanced Melanoma Ignyte-3](https://www.sutterhealth.org/research/clinical-trials/advanced-melanoma-ignyte-3-1095539355)
    
    Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs Treatment of Physician's Choice in Patients With Advanced Melanoma That Progressed on Anti-PD-1 and Anti-CTLA-4 Containing Treatment
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Advanced or Metastatic Non-Small Cell Lung Cancer C6461001](https://www.sutterhealth.org/research/clinical-trials/advanced-or-metastatic-non-small-cell-lung-cancer-c6461001-2046372288)
    
    An Interventional Phase 3, Double-blind, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy Versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Locally Advanced or Metastatic Non-small Cell Lung Cancer
    
    **Status:** Open to Enrollment
    

Page 1 of 3

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"Dron Gauchan, M.D."}]}
```

```json
{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200#profilepage","url":"https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200","name":"Dron Gauchan, M.D.","dateModified":"2026-06-03","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/0fCyS_704YpY2A8viqU-BukeGy4TDdCv0qxgxLEceLs/460x460.webp","width":460,"height":460},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200"}}
```

```json
{"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200","name":"Dron Gauchan, M.D.","givenName":"Dron","familyName":"Gauchan","honorificSuffix":"M.D.","description":"Dr. Gauchan serves as the Associate Program Director and Chair of the Oncology Department. He is a board-certified Hematologist and Medical Oncologist with clinical expertise in lung cancer, glioblastoma, and genitourinary and gastrointestinal malignancies. He is also the Medical Director of Oncology Clinical Informatics. In addition to his clinical responsibilities, Dr. Gauchan holds several key leadership roles within Sutter Medical Group and Sutter Health. He serves as a member of the Executive Council for the Sutter Health Cancer Service Line and as Director of Pharmacy and Infusion Services. Despite his extensive administrative duties, he remains deeply dedicated to education and mentorship, bringing a wealth of experience in training both medical students and residents. His comprehensive knowledge and commitment to teaching will be an invaluable asset to our Hematology and Oncology Fellowship Program. Dr. Gauchan completed his Internal Medicine residency at St. Joseph’s University Hospital, followed by a fellowship in Hematology and Medical Oncology at Seton Hall University in New Jersey, where he also served as Chief Fellow. He is actively involved in research and serves as Principal Investigator for multiple cutting-edge clinical trials at the Sutter Roseville Cancer Center. His scholarly contributions include numerous publications in peer-reviewed journals. As part of his commitment to ongoing education, Dr. Gauchan co-chairs the annual Sutter Health Hematology and Medical Oncology Conference in Sacramento, as well as the San Francisco Lung Cancer Conference in collaboration with faculty from Stanford and UCSF. Fellows in our program will benefit from meaningful participation in these highly regarded conferences. Outside of his professional endeavors, Dr. Gauchan enjoys traveling, hiking, skiing, and discovering new cultures. His passion for engaging with people from diverse backgrounds and exploring global cuisines reflects the inclusive and open-minded approach he brings to both his personal and professional life. Dr. Gauchan’ s clinical expertise, leadership, and passion for education will greatly enrich our fellowship program and play a key role in the growth and success of our fellows.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/0fCyS_704YpY2A8viqU-BukeGy4TDdCv0qxgxLEceLs/460x460.webp","representativeOfPage":true},"address":{"@type":"PostalAddress","streetAddress":"8 Medical Plaza Drive Suite 300","addressLocality":"Roseville","addressRegion":"CA","postalCode":"95661","addressCountry":"US"},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/dron-gauchan-md-1049681200#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-dron-gauchan-1046248966"}
```
